Pregled bibliografske jedinice broj: 550425
Maternal efficacy and safety outcomes ina a radnomized trial comparing insulin detemir with NPH insulin in 313 pregnant women with type 1 diabetes
Maternal efficacy and safety outcomes ina a radnomized trial comparing insulin detemir with NPH insulin in 313 pregnant women with type 1 diabetes // Abstracts of the 47th Annual Meeting of the EASD ; u: Diabetologia (Berlin) 54(2011) (S1) ; 1-542
Lisabon, Portugal, 2011. str. 487-487 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 550425 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Maternal efficacy and safety outcomes ina a radnomized trial comparing insulin detemir with NPH insulin in 313 pregnant women with type 1 diabetes
Autori
Mathiesen, Elisabeth R. ; Damm, Peter ; Hod, Moshe ; Ivanišević, Marina ; Duran Garcia, S. ; Jovanović, Lois
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the 47th Annual Meeting of the EASD ; u: Diabetologia (Berlin) 54(2011) (S1) ; 1-542
/ - , 2011, 487-487
Skup
Annual Meeting of the EASD (47 ; 2011)
Mjesto i datum
Lisabon, Portugal, 2011
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
detemir; NPH insulin; type 1 diabetes
Sažetak
The aim of this prospective, randomized, controlled, parallel-group, open-label trial as to compare the efficacy and safety of insulin detemir (IDet) vs. NPH (both ith prandial insulin aspart) in pregnant vvomen ith type 1 diabetes (T1DM). T1DM vvomen (HbA1c <8 % at pregnancy confirmation) ere randomized to IDet (n=152) or NPH (n=161) up to 12 months before pregnancy or during pregnancy at 8-12 eeks gestation. The primary objective as to confirm efficacy of IDet by shovving that IDet as non-inferior to NPH ith respect to HbA1c at 36 gestational vveeks (GVVs) (primao/ endpoint). Non-inferiority as shovvn if the upper limit of the 95% Cl for the treatment difference of IDet vs. NPH as belovv the pre-specified non-inferior^ margin of 0.4% for both the Full Analysis Set (FAS) and Per Protocol Set (PP). The data ere analvzed using linear regression. 79 and 83 vvomen in the IDet and NPH groups, respectively, ere pregnant at randomization vvhile 73 and 75 vvomen, respectively, became pregnant follovving randomization. Mean (SD) baseline demographics ere: age 30.1 (4.4) yrs ; BMI 24.8 (4.1) kg/m2 ; HbA1c 7.01 (0.79) % ; fasting plasma glucose (FPG) 5.94 (3.25) mmol/l and diabetes duration 12.3 (8.0) yrs. For FAS, the estimated HbA1c at GVV36 as 6.27% for IDet and 6.33% for NPH. IDetvvas declared non-inferior to NPH (FAS: -0.06%, 95% Cl: [-0.21 ; 0.08] % ; PP: -1.5% ; 95% Cl: [-0.34 ; 0.04]%). FPG as significantly lovver ith IDet vs. NPH (table). Hypoglycemia rates ere similar betvveen groups. In summary, lovver FPG, but equivalent HbA1c in late pregnancy ere obtained using insulin detemir in comparison to NPH insulin in vvomen ith T1DM .
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-1080401-0385 - Dijabetes i metabolički sindrom nakon prethodnog gestacijskog dijabetesa (Ivanišević, Marina, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Marina Ivanišević
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE